Skip to Content

Solar Is a Booming Business, but It’s Still Not Generating Much of Our Power

Solar capacity is on the rise, but it still accounts for only about 1 percent of the world’s electricity.
March 23, 2016

The solar industry is growing fast. Led by China, the United States, and Japan, the world will install nearly 65 gigawatts of new solar generating capacity this year—up from 54 gigawatts in 2015 and four times the amount installed in 2010.

Solar now represents somewhere between 3 and 4 percent of the world’s total generating capacity. But capacity, which is the maximum amount of electricity that a power plant can supply and varies according to the amount of sunlight available, is a lot different from the amount of electricity a plant actually generates. In 2014, only about 0.8 percent of the world’s electricity came from the sun. Last year, solar power may have finally covered more than 1 percent of global energy demand.

In 2014, 19 countries, most in Europe, produced at least 1 percent of their electricity using photovoltaic panels. Germany gets more than 7 percent of its electricity from solar. Japan gets 2.5 percent from solar. Meanwhile, China and the U.S.—the two biggest builders of solar capacity in 2016—have yet to officially cross the 1 percent line.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.